Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK.
Crit Care. 2010;14(4):188. doi: 10.1186/cc9190. Epub 2010 Aug 9.
Severe acute pancreatitis (SAP) is characterized by an unregulated systemic proinflammatory response secondary to activation of trypsin within the pancreatic tissue, resulting in multiple organ failure. This dysregulated inflammation leading to organ dysfunction also characterizes severe sepsis. Activated protein C (APC) has pleotropic effects on the immune, coagulation, inflammatory and apoptotic pathways, and has been postulated to benefit acute pancreatitis--although concerns of possible retroperitoneal bleeding remain. Currently, experimental studies and subgroup data on patients with pancreatitis from a randomized controlled trial of APC in severe sepsis form the literature on the possible role of APC in SAP. We review the first randomized controlled trial of APC in acute pancreatitis published in the present issue of Critical Care.
重症急性胰腺炎(SAP)的特征是由于胰腺组织内的胰蛋白酶激活,导致全身炎症反应失控,进而引发多器官衰竭。这种失调的炎症导致器官功能障碍,也是严重脓毒症的特征。活化蛋白 C(APC)对免疫、凝血、炎症和凋亡途径具有多种作用,并被推测对急性胰腺炎有益——尽管仍存在对可能的腹膜后出血的担忧。目前,关于严重脓毒症中 APC 的随机对照试验的胰腺炎患者的实验研究和亚组数据构成了关于 APC 在 SAP 中可能作用的文献。我们回顾了本期《危重病医学》上发表的急性胰腺炎中 APC 的首个随机对照试验。